Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: results of the Phase III Albunex Multicenter Trial

Department of Cardiology, Mid-America Cardiology Associates, Kansas City, Missouri 64111.

OBJECTIVES. This study was designed to assess the safety and efficacy of intravenously administered sonicated human serum albumin for enhancing echocardiographic delineation of the left ventricular endocardium and improving assessment of wall motion in patients with incomplete depiction of noncontrast echocardiography. BACKGROUND. Echocardiographic regional wall motion analysis is impaired by incomplete endocardial definition in as many as 10% of patients. Sonicated human serum albumin is a stable contrast material that, unlike other agents, opacifies the left ventricle when administered intravenously. METHODS. One hundred seventy-five patients were enrolled at eight centers on the basis of incomplete echocardiographic endocardial depiction. Sonicated 5% human serum albumin, a stable preparation of air-filled microspheres (size range 1 to 10 microns), was administered intravenously in divided doses: 0.08 ml/kg body weight in all patients, followed by 0.14 and 0.08 ml/kg or a single dose of 0.22 ml/kg, depending on the result of the initial dose. Investigators and independent reviewers blinded to the protocol scored the echocardiograms for degree of left ventricular opacification and improvement of endocardial border depiction. RESULTS. Overall, 81% of patients had at least moderate left ventricular chamber opacification with at least one contrast dose, and endocardial definition was improved in 83%. In the subgroup with inadequate left ventricular opacification from the initial dose, a second, larger dose (0.22 ml/kg) improved endocardial depiction in 64%. No significant side effects occurred. CONCLUSIONS. In patients with incomplete echocardiographic endocardial definition, sonicated human serum albumin is a safe, effective contrast agent that, when administered intravenously, produces left ventricular chamber opacification, improves endocardial depiction and enhances regional wall motion analysis.

This article has been cited by other articles:

				P. H. Jung, J. Rieber, S. Stork, C. Hoyer, I. Erhardt, A. Nowotny, W. Voelker, F. Weidemann, G. Ertl, V. Klauss, et al. Effect of contrast application on interpretability and diagnostic value of dobutamine stress echocardiography in patients with intermediate coronary lesions: comparison with myocardial fractional flow reserve Eur. Heart J., October 2, 2008; 29(20): 2536 - 2543. [Abstract] [Full Text] [PDF]

				R. Sicari, P. Nihoyannopoulos, A. Evangelista, J. Kasprzak, P. Lancellotti, D. Poldermans, J.-U. Voigt, J. L. Zamorano, and on behalf of the European Association of Echocardi Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC) Eur J Echocardiogr, July 1, 2008; 9(4): 415 - 437. [Abstract] [Full Text] [PDF]

				M. L. Main, J. H. Goldman, and P. A. Grayburn Thinking Outside the "Box" The Ultrasound Contrast Controversy J. Am. Coll. Cardiol., December 18, 2007; 50(25): 2434 - 2437. [Abstract] [Full Text] [PDF]

				R. Olszewski, J. Timperley, S. Cezary, M. Monaghan, P. Nihoyannopoulis, R. Senior, and H. Becher The clinical applications of contrast echocardiography Eur J Echocardiogr, June 1, 2007; 8(3): s13 - s23. [Full Text] [PDF]

				G. A. Whalley, G. D. Gamble, H. J. Walsh, N. Sharpe, and R. N. Doughty Quantitative evaluation of regional endocardial visualisation with second harmonic imaging and contrast left ventricular opacification in heart failure patients Eur J Echocardiogr, March 1, 2005; 6(2): 134 - 143. [Abstract] [Full Text] [PDF]

				A.E. van den Bosch, F.J. Meijboom, J.S. McGhie, J.W. Roos-Hesselink, F.J. Ten Cate, and J.R.T.C. Roelandt Enhanced visualisation of the right ventricle by contrast echocardiography in congenital heart disease Eur J Echocardiogr, March 1, 2004; 5(2): 104 - 110. [Abstract] [Full Text] [PDF]

				S. Schalla, C. Klein, I. Paetsch, H. Lehmkuhl, A. Bornstedt, B. Schnackenburg, E. Fleck, and E. Nagel Real-Time MR Image Acquisition during High-Dose Dobutamine Hydrochloride Stress for Detecting Left Ventricular Wall-Motion Abnormalities in Patients with Coronary Arterial Disease Radiology, September 1, 2002; 224(3): 845 - 851. [Abstract] [Full Text] [PDF]

				H. Becher, K. Tiemann, S. Kuntz-Hehner, H. Omran, and T. Schlosser Diagnostic impact of contrast echocardiography for assessment of left ventricular function and myocardial perfusion in patients with coronary artery disease Eur. Heart J. Suppl., March 1, 2002; 4(suppl_C): C12 - C21. [Abstract] [PDF]

				A. Distante, R. Dankowski, P. Mincarone, C.G. Leo, E. Gianicolo, P. Voci, M.A. Morales, and D. Rovai Contrast echocardiography and medical economics: looking into the crystal ball Eur. Heart J. Suppl., March 1, 2002; 4(suppl_C): C39 - C47. [Abstract] [PDF]

				T. T. Nguyen, M. R. Dhond, R. Sabapathy, and W. J. Bommer Contrast Microbubbles Improve Diagnostic Yield in ICU Patients With Poor Echocardiographic Windows Chest, October 1, 2001; 120(4): 1287 - 1292. [Abstract] [Full Text] [PDF]

				H. L. Thomson, A.-J. Basmadjian, A. J. Rainbird, M. Razavi, J.-F. Avierinos, P. A. Pellikka, K. R. Bailey, J. F. Breen, and M. Enriquez-Sarano Contrast echocardiography improves the accuracy and reproducibility of left ventricular remodeling measurements: A prospective, randomly assigned, blinded study J. Am. Coll. Cardiol., September 1, 2001; 38(3): 867 - 875. [Abstract] [Full Text] [PDF]

				G. Mychaskiw II, A. E. Badr, R. Tibbs, B. R. Clower, and J. H. Zhang Optison (FS069) Disrupts the Blood-Brain Barrier in Rats Anesth. Analg., October 1, 2000; 91(4): 798 - 803. [Abstract] [Full Text] [PDF]

				F. F. Immer, A. M. Seiler, B. C. Aeschbacher, F. Mahler, H. Saner, and H. Saner Influence of the Ultrasound Contrast Agent Levovist(R) on Human Nailfold Capillary Microcirculation Angiology, February 1, 2000; 51(2): 123 - 129. [Abstract] [PDF]

				F. Forsberg, B. B. Goldberg, J.-B. Liu, D. A. Merton, N. M. Rawool, and W. T. Shi Tissue-Specific US Contrast Agent for Evaluation of Hepatic and Splenic Parenchyma Radiology, January 1, 1999; 210(1): 125 - 132. [Abstract] [Full Text]

				P. C. Yang, A. B. Kerr, A. C. Liu, D. H. Liang, C. Hardy, C. H. Meyer, A. Macovski, J. M. Pauly, and B. S. Hu New real-time interactive cardiac magnetic resonance imaging system complements echocardiography J. Am. Coll. Cardiol., December 1, 1998; 32(7): 2049 - 2056. [Abstract] [Full Text] [PDF]

				W. G. Hundley, A. M. Kizilbash, I. Afridi, F. Franco, R. M. Peshock, and P. A. Grayburn Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: comparison with cine magnetic resonance imaging J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1426 - 1432. [Abstract] [Full Text] [PDF]

				J. L. Cohen, J. Cheirif, D. S. Segar, L. D. Gillam, J. S. Gottdiener, E. Hausnerova, and D. E. Bruns Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent: Results of a phase III multicenter trial J. Am. Coll. Cardiol., September 1, 1998; 32(3): 746 - 752. [Abstract] [Full Text] [PDF]

				P. A. Grayburn, J. L. Weiss, T. C. Hack, E. Klodas, J. S. Raichlen, M. A. Vannan, A. L. Klein, D. W. Kitzman, S. G. Chrysant, J. L. Cohen, et al. Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms J. Am. Coll. Cardiol., July 1, 1998; 32(1): 230 - 236. [Abstract] [Full Text] [PDF]